Severe SMA mice show organ impairment that cannot be rescued by therapy with the HDACi JNJ-26481585
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Severe SMA mice show organ impairment that cannot be rescued by therapy with the HDACi JNJ-26481585
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HUMAN GENETICS
Volume 21, Issue 6, Pages 643-652
Publisher
Springer Nature
Online
2012-10-17
DOI
10.1038/ejhg.2012.222
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TSUNAMI: an antisense method to phenocopy splicing-associated diseases in animals
- (2012) K. Sahashi et al. GENES & DEVELOPMENT
- HDAC inhibitor M344 suppresses MCF-7 breast cancer cell proliferation
- (2011) Angie Yeung et al. BIOMEDICINE & PHARMACOTHERAPY
- mRNA Expression Signatures of Human Skeletal Muscle Atrophy Identify a Natural Compound that Increases Muscle Mass
- (2011) Steven D. Kunkel et al. Cell Metabolism
- Increased IGF-1 in muscle modulates the phenotype of severe SMA mice
- (2011) Marta Bosch-Marcé et al. HUMAN MOLECULAR GENETICS
- Reversible molecular pathology of skeletal muscle in spinal muscular atrophy
- (2011) Chantal A. Mutsaers et al. HUMAN MOLECULAR GENETICS
- A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse
- (2011) Paul N. Porensky et al. HUMAN MOLECULAR GENETICS
- Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
- (2011) Yimin Hua et al. NATURE
- A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology
- (2011) Mélissa Bowerman et al. NEUROMUSCULAR DISORDERS
- Density, calibre and ramification of muscle capillaries are altered in a mouse model of severe spinal muscular atrophy
- (2011) E. Somers et al. NEUROMUSCULAR DISORDERS
- SMA CARNI-VAL TRIAL PART II: A Prospective, Single-Armed Trial of L-Carnitine and Valproic Acid in Ambulatory Children with Spinal Muscular Atrophy
- (2011) John T. Kissel et al. PLoS One
- Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy
- (2011) M. A. Passini et al. Science Translational Medicine
- Preclinical anti-myeloma activity of the novel HDAC-inhibitor JNJ-26481585
- (2010) Thorsten Stühmer et al. BRITISH JOURNAL OF HAEMATOLOGY
- SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy
- (2010) Markus Riessland et al. HUMAN MOLECULAR GENETICS
- Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice
- (2010) Christopher R. Heier et al. HUMAN MOLECULAR GENETICS
- Cardiac defects contribute to the pathology of spinal muscular atrophy models
- (2010) Monir Shababi et al. HUMAN MOLECULAR GENETICS
- Early heart failure in the SMNΔ7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery
- (2010) Adam K. Bevan et al. HUMAN MOLECULAR GENETICS
- Deficiency of the splicing factor Sfrs10 results in early embryonic lethality in mice and has no impact on full-length SMN/Smn splicing
- (2010) Ylva Mende et al. HUMAN MOLECULAR GENETICS
- Spinal muscular atrophy: mechanisms and therapeutic strategies
- (2010) C. L. Lorson et al. HUMAN MOLECULAR GENETICS
- Quantification of SMN protein in leucocytes from spinal muscular atrophy patients: effects of treatment with valproic acid
- (2010) S. Piepers et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- SMA CARNI-VAL Trial Part I: Double-Blind, Randomized, Placebo-Controlled Trial of L-Carnitine and Valproic Acid in Spinal Muscular Atrophy
- (2010) Kathryn J. Swoboda et al. PLoS One
- JNJ-26481585, a Novel "Second-Generation" Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity
- (2009) J. Arts et al. CLINICAL CANCER RESEARCH
- Emerging treatment options for spinal muscular atrophy
- (2009) Barrington G. Burnett et al. Current Treatment Options in Neurology
- LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate
- (2009) Lutz Garbes et al. HUMAN MOLECULAR GENETICS
- Pre-symptomatic development of lower motor neuron connectivity in a mouse model of severe spinal muscular atrophy
- (2009) Lyndsay M. Murray et al. HUMAN MOLECULAR GENETICS
- The effects of JNJ-26481585, a novel hydroxamate-based histone deacetylase inhibitor, on the development of multiple myeloma in the 5T2MM and 5T33MM murine models
- (2009) S Deleu et al. LEUKEMIA
- Preclinical antileukemia activity of JNJ-26481585, a potent second-generation histone deacetylase inhibitor
- (2009) Wei-Gang Tong et al. LEUKEMIA RESEARCH
- Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation
- (2009) E Borbone et al. ONCOGENE
- Congenital heart defects in spinal muscular atrophy type I: A clinical report of two siblings and a review of the literature
- (2008) Leonie A. Menke et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Identification of a battery of tests for drug candidate evaluation in the SMNΔ7 neonate model of spinal muscular atrophy
- (2008) Bassem F. El-Khodor et al. EXPERIMENTAL NEUROLOGY
- Mutation update of spinal muscular atrophy in Spain: molecular characterization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene
- (2008) Laura Alías et al. HUMAN GENETICS
- Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition
- (2008) Jan Hauke et al. HUMAN MOLECULAR GENETICS
- Malignant Ventricular Arrhythmia in a Case of Adult Onset of Spinal Muscular Atrophy (Kugelberg-Welander Disease)
- (2008) MARKUS ROOS et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice
- (2008) Li-Kai Tsai et al. JOURNAL OF MOLECULAR MEDICINE-JMM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now